KMC Speciality Hospitals (India) Ltd524520Corporate

Hospital Latest results: Jun 2026 14 quarters of data
₹148.30
MCap ₹2,373 Cr · P/E 41.9
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹92 Cr
Sales · Jun 2026
+37.0% YoY
₹28 Cr
Operating Profit · Jun 2026
+78.0% YoY
31.0%
OPM % · Jun 2026
+29.7% YoY
₹17 Cr
Net Profit · Jun 2026
+107.2% YoY
₹1.02
EPS · Jun 2026
+121.7% YoY

📝 KMC Speciality Hospitals (India) Ltd — results explained

Quarter ended June 2026 (Q1 FY27)

KMC Speciality Hospitals (India) Ltd reported revenue of ₹92 crore for the quarter ended June 2026 (Q1 FY27), up 37.0% from ₹67 crore in the same quarter last year, and up 11.9% sequentially over the March 2026 quarter.

Net profit rose 107.2% year-on-year to ₹17 crore, from ₹8 crore. Earnings per share (EPS) came in at ₹1.02.

Operating profit stood at ₹28 crore — an operating margin (OPM) of 31.0%, compared with 23.9% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, KMC Speciality Hospitals (India) Ltd posted revenue of ₹306 crore, a growth of 32.5% over FY25, with a net profit of ₹48 crore (up 108.7% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹331 crore with a net profit of ₹57 crore.

Valuation snapshot

At the current price of ₹148.30, 524520 has a market capitalisation of ₹2,373 crore and a trailing P/E of about 41.9.

Within the Hospital industry, it is the 3rd-largest of the 10 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 75.00%, foreign institutional investors (FIIs) 0.02%, public shareholders 24.98% of KMC Speciality Hospitals (India) Ltd.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹2,373 Cr
Current Price ?
₹148.3
P/E ?
41.94above ind
Industry P/E ?
39.60
P/B ?
11.30
P/S ?
7.17
P/FCF ?
37.66
Enterprise Value ?
₹2,457 Cr
EV/EBITDA ?
24.45
PEG ?
2.10
Earnings Yield ?
3.2%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹331 Cr
OPM ?
30.4%
Profit after tax (TTM) ?
₹57 Cr
EPS (TTM) ?
₹3.54
ROCE ?
26.0%
ROE ?
26.9%
ROA ?
17.0%
Growth
Sales — latest qtr ?
₹92 Cr
PAT — latest qtr ?
₹17 Cr
YoY qtr sales growth ?
37.0%
YoY qtr profit growth ?
107.2%
Sales growth (3y) ?
25%
Sales growth (5y) ?
24%
Profit growth (3y) ?
20%
Profit growth (5y) ?
30%
Financial Health
Debt ?
₹84 Cr
Debt to Equity ?
0.40
Interest Coverage ?
8.4
Current Ratio ?
N/A
Ownership
Promoter holding ?
75.00%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
26.3%
Return 6 months ?
83.0%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 4141424945535661616775828292 +37.0% +11.9%
Operating Profit 1110111412131316151621252628 +78.0% +9.6%
Other Income 12111101111122 +80.8% -9.6%
Interest 00000232222222 +0.1% +0.1%
Depreciation 22223455555566 +17.0% -2.5%
Profit Before Tax 1099129751091015182022 +124.4% +12.2%
Net Profit 777976485811141517 +107.2% +10.5%
EPS 0.450.430.420.580.430.340.240.460.280.460.660.840.901.02 +121.7% +13.3%
OPM % 26.8% 24.4% 26.2% 28.6% 26.7% 24.5% 23.2% 26.2% 24.6% 23.9% 28.0% 30.5% 31.7% 31.0% +29.7% -2.2%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹231 Cr ₹306 Cr ₹331 Cr +32.5%
Operating Profit ₹57 Cr ₹88 Cr ₹100 Cr +54.4%
OPM % 24.68% 28.76% 30.38% +16.5%
NPM % 9.96% 15.69% 17.10% +57.5%
Other Income ₹3 Cr ₹5 Cr ₹6 Cr +66.7%
Depreciation ₹19 Cr ₹21 Cr ₹22 Cr +10.5%
Interest ₹9 Cr ₹8 Cr ₹8 Cr -11.1%
EBIT ₹38 Cr ₹67 Cr ₹79 Cr +76.3%
PBT ₹31 Cr ₹63 Cr ₹75 Cr +103.2%
Tax — — ₹6 Cr —
Net Profit ₹23 Cr ₹48 Cr ₹57 Cr +108.7%
EPS ₹1.32 ₹2.86 ₹3.42 +116.7%
Material Cost — — ₹12 Cr —
Employee Cost — — ₹20 Cr —
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 16161616 +0.0%
Reserves 97127148194 +31.1%
Borrowings 50828984 -5.6%
Other Liabilities 18383238 +18.8%
Total Liabilities 182264286332 +16.1%
Fixed Assets 84206248248 +0.0%
CWIP 34100 —
Investments 0000 —
Other Assets 63573884 +121.1%
Total Assets 182264286332 +16.1%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 32385879 +36.2%
Cash from Investing Activity -48-56-51-17 +66.7%
Cash from Financing Activity 1620-2-21 -950.0%
Net Cash Flow 03441 +925.0%
Free Cash Flow -12-37-663 +1150.0%
CFO/OP 100%101%112%100% -10.7%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 10999 +0.0%
Inventory Days 36313831 -18.4%
Days Payable 10211315382 -46.4%
Cash Conversion Cycle -56-73-105-42 +60.0%
Working Capital Days -22-73-22-19 +13.6%
ROCE % 27%22%17%26% +52.9%

👥 Shareholding (latest 4 periods)

Metric Sep 2025Dec 2025Mar 2026Jun 2026 % Chg
Promoters 75.00%75.00%75.00%75.00% +0.0%
FIIs 0.00%0.00%0.00%0.02% —
Public 25.00%24.99%25.01%24.98% -0.1%
No. of Shareholders 86,95886,34486,31888,487 +2.5%

⚖️ Peer comparison

Industry: Hospital · 10 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 PARKHOSPS Park Medi ₹280.90 12,133 42.4 1,756 298 26.5% 16.9% — — 19.3% 34.8%
2 526783 Dr Agarwals ₹5,253.00 2,465 33.3 497 75 30.4% 15.2% 18.6% 27.8% 22.2% 37.5%
3 524520 KMC Speciality ₹81.32 2,373 23.8 331 57 30.4% 17.1% 32.5% 108.7% 37.0% 107.2%
4 GKSL Gujarat Kidney ₹172.33 1,359 — — — — — — — — —
5 543346 Aashka Hospitals ₹117.80 195 83.0 23 3 22.8% 14.5% — — 22.3% 55.2%
6 531658 Abate As ₹28.64 120 266.9 — 2 — — — 158.6% — 10.1%
7 523696 Fortis Malar ₹65.66 79 n/m 0 0 -5165.0% 427.8% — 932.5% -95.5% -96.3%
8 544013 KK Shah ₹49.79 30 — 9 -1 8.2% -6.6% — — -7.2% 57.1%
9 539378 Soni Medicare ₹26.49 30 — 23 -4 -8.1% -15.5% -15.9% -1405.6% -39.2% -313.3%
10 543520 Global Longlife ₹30.99 16 — — -2 — — — — — 61.5%
❓ Frequently asked questions
What was KMC Speciality Hospitals (India) Ltd's revenue in Q1 FY27?
KMC Speciality Hospitals (India) Ltd reported revenue of ₹92 crore for the quarter ended June 2026 (Q1 FY27), up 37.0% from ₹67 crore in the same quarter last year, and up 11.9% sequentially over the March 2026 quarter.
What was KMC Speciality Hospitals (India) Ltd's net profit in Q1 FY27?
Net profit rose 107.2% year-on-year to ₹17 crore, from ₹8 crore. Earnings per share (EPS) came in at ₹1.02.
What is 524520's market capitalisation and P/E ratio?
At the current price of ₹148.30, 524520 has a market capitalisation of ₹2,373 crore and a trailing P/E of about 41.9.
Who owns KMC Speciality Hospitals (India) Ltd? (shareholding pattern)
As of Jun 2026, promoters held 75.00%, foreign institutional investors (FIIs) 0.02%, public shareholders 24.98% of KMC Speciality Hospitals (India) Ltd.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI